Ligand validation:3WF3

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 3WF3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3WF3_GAL_D_706	85%	56%	0.085	0.95	0.7	0.98	-	1	2	0	100%	1
3WF3_GAL_C_706	82%	52%	0.111	0.966	0.85	1.02	-	1	1	0	100%	1
3WF3_GAL_A_705	77%	52%	0.107	0.948	0.74	1.12	-	2	0	0	100%	1
3WF3_GAL_B_710	74%	45%	0.106	0.937	0.89	1.25	-	2	1	0	100%	1
3THC_GAL_C_900	95%	61%	0.07	0.972	0.63	0.85	-	1	1	0	100%	1
5ELB_GAL_C_202	100%	57%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
4WWH_GAL_B_401	100%	61%	0.047	0.993	0.51	0.97	-	1	0	0	100%	1
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1
2EUK_GAL_A_300	98%	59%	0.053	0.973	0.56	0.97	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.